piracetam has been researched along with Tourette Syndrome in 6 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Tourette Syndrome: A neuropsychological disorder related to alterations in DOPAMINE metabolism and neurotransmission involving frontal-subcortical neuronal circuits. Both multiple motor and one or more vocal tics need to be present with TICS occurring many times a day, nearly daily, over a period of more than one year. The onset is before age 18 and the disturbance is not due to direct physiological effects of a substance or another medical condition. The disturbance causes marked distress or significant impairment in social, occupational, or other important areas of functioning. (From DSM-IV, 1994; Neurol Clin 1997 May;15(2):357-79)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the usefulness of levetiracetam (LEV) for the treatment of tics in patients with Tourette syndrome (TS) by means of a prospective, open-label, 12-week study." | 9.14 | An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome. ( Calleja-Pérez, B; Fernández-Jaén, A; Fernández-Mayoralas, DM; Muñoz-Jareño, N, 2009) |
| "We compared the efficacy of clonidine and levetiracetam for treating tics in Tourette syndrome." | 9.14 | Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. ( Hedderick, EF; Morris, CM; Singer, HS, 2009) |
| "The objective of this study was to investigate the effectiveness of levetiracetam for the treatment of tics in children with Tourette syndrome (TS)." | 9.12 | A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. ( Bridges, DD; Paynter, NP; Singer, HS; Smith-Hicks, CL, 2007) |
| "Levetiracetam, an anti-epileptic agent that enhances GABAergic neurotransmission, is one of the newest alternative treatments of Tourette syndrome (TS)." | 7.74 | Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome. ( Karakatsanis, NA; Karapoulios, E; Kouzoupis, AV; Masdrakis, VG; Oulis, P; Papadimitriou, GN; Papageorgiou, C; Soldatos, CR, 2008) |
| "Levetiracetam is an antiepileptic drug with atypical mechanisms of action that might be beneficial for this indication." | 6.71 | Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. ( Awaad, Y; Michon, AM; Minarik, S, 2005) |
| "To evaluate the usefulness of levetiracetam (LEV) for the treatment of tics in patients with Tourette syndrome (TS) by means of a prospective, open-label, 12-week study." | 5.14 | An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome. ( Calleja-Pérez, B; Fernández-Jaén, A; Fernández-Mayoralas, DM; Muñoz-Jareño, N, 2009) |
| "We compared the efficacy of clonidine and levetiracetam for treating tics in Tourette syndrome." | 5.14 | Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. ( Hedderick, EF; Morris, CM; Singer, HS, 2009) |
| "The objective of this study was to investigate the effectiveness of levetiracetam for the treatment of tics in children with Tourette syndrome (TS)." | 5.12 | A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. ( Bridges, DD; Paynter, NP; Singer, HS; Smith-Hicks, CL, 2007) |
| "Levetiracetam, an anti-epileptic agent that enhances GABAergic neurotransmission, is one of the newest alternative treatments of Tourette syndrome (TS)." | 3.74 | Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome. ( Karakatsanis, NA; Karapoulios, E; Kouzoupis, AV; Masdrakis, VG; Oulis, P; Papadimitriou, GN; Papageorgiou, C; Soldatos, CR, 2008) |
| "Levetiracetam is an antiepileptic drug with atypical mechanisms of action that might be beneficial for this indication." | 2.71 | Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. ( Awaad, Y; Michon, AM; Minarik, S, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Jaén, A | 1 |
| Fernández-Mayoralas, DM | 1 |
| Muñoz-Jareño, N | 1 |
| Calleja-Pérez, B | 1 |
| Hedderick, EF | 1 |
| Morris, CM | 1 |
| Singer, HS | 2 |
| Jiménez-Genchi, A | 1 |
| Ávila-Ordóñez, MU | 1 |
| Félix-Orta, F | 1 |
| Ballesteros-Montero, AT | 1 |
| Awaad, Y | 1 |
| Michon, AM | 1 |
| Minarik, S | 1 |
| Smith-Hicks, CL | 1 |
| Bridges, DD | 1 |
| Paynter, NP | 1 |
| Oulis, P | 1 |
| Karapoulios, E | 1 |
| Masdrakis, VG | 1 |
| Kouzoupis, AV | 1 |
| Karakatsanis, NA | 1 |
| Papageorgiou, C | 1 |
| Papadimitriou, GN | 1 |
| Soldatos, CR | 1 |
4 trials available for piracetam and Tourette Syndrome
| Article | Year |
|---|---|
An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome.
Topics: Adolescent; Child; Dose-Response Relationship, Drug; Female; Humans; Levetiracetam; Male; Nootropic | 2009 |
Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Child; Clonidine; Confidence Intervals; Cross-Sectiona | 2009 |
Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome.
Topics: Adolescent; Anticonvulsants; Child; Demography; Dose-Response Relationship, Drug; Educational Status | 2005 |
A double blind randomized placebo control trial of levetiracetam in Tourette syndrome.
Topics: Adolescent; Anticonvulsants; Child; Confidence Intervals; Dose-Response Relationship, Drug; Double-B | 2007 |
2 other studies available for piracetam and Tourette Syndrome
| Article | Year |
|---|---|
[Frontal lobe nocturnal epilepsy in an adult with Gilles de la Tourette syndrome].
Topics: Adult; Anticonvulsants; Epilepsy, Frontal Lobe; Humans; Levetiracetam; Male; Piracetam; Polysomnogra | 2011 |
Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome.
Topics: Adrenergic alpha-Agonists; Adult; Anti-Dyskinesia Agents; Anticonvulsants; Antipsychotic Agents; Clo | 2008 |